Millions of men each year have their blood tested for prostate specific antigen, or PSA, a normal protein whose levels may be elevated in men with prostate cancer or other benign diseases of the prostate. However, experts have disagreed on who should be tested, when and how frequently. Some are concerned about whether the benefits outweigh the risks of overdiagnosis and overtreatment. In fact, a federal advisory task force in 2012 recommended against routine PSA testing for healthy men – though many physicians disagreed.
by Eric Schuller For many cancer patients, the Internet serves as a vital tool used to stay in touch with loved ones during treatment, find comfort and advice from other patients and caregivers, or even research clinical trials. But using the Web to learn more about a cancer diagnosis or potential treatments requires a healthy dose of caution. For all of its many benefits, the Internet used unwisely can lead to scams and misinformation, as well.
by Richard Saltus One of the oldest healing practices in the world, acupuncture is beginning to have a role in alleviating pain and discomfort associated with cancer and its treatments. Acupuncturists use fine needles to penetrate the skin and stimulate – manually or electrically – specific points on the body. Stimulation at these points, according to traditional Chinese medicine, corrects imbalance in the flow of qi – a type of energy that flows through channels known as meridians. Dana-Farber staff acupuncturist Weidong Lu, MB, MPH, PhD, of the Leonard P. Zakim Center for Integrative Therapies, has been using the technique with …
Quite a few substances used in traditional medicine in China or other countries have received Food and Drug Administration (FDA) approval as cancer drugs… and their numbers are growing. Some examples are: Arsenic trioxide, made from arsenic sulfide ore, has been used therapeutically for more than 2,400 years. Following promising reports from China, the agent was tested in clinical trials and received FDA approval in 2000 for patients with acute promyelocytic leukemia who have not responded to other therapies or whose disease has recurred.
One of the goals of the Rally for Medical Research, held in conjunction with the American Association for Cancer Research (AACR) 2013 Annual Meeting, earlier this month was to bring awareness to and education about the impact of the cuts in federal funding for medical research. Dana-Farber’s Kenneth C. Anderson, MD participated in the Rally. He says in this video, that the scientists who exist today are extraordinary, and for the new generation of cancer researchers to build on today’s advances, it is all dependent on funding from the National Institutes of Health and the National Cancer Institute.
If you have your first chemotherapy appointment coming up, you’re likely thinking about a hundred things. In this short video, a Dana-Farber breast cancer patient walks us through the chemotherapy infusion process. If you’re anxious about your first chemo appointment, the video is a good place to start. If you’re also wondering about the logistics of it all, here are some practical tips gathered from patients who have been there.
by Naomi Funkhouser April 2011 was an auspicious month for Hilary Hall. The start of spring marked 15 years of her being cancer-free, as well as the anniversary of her bone marrow transplant in April 1996 at age 12 for acute myelogenous leukemia. It also marked the first time Hall would lace up her running shoes for the Boston Marathon. “When I heard about the marathon in October 2010, I instantly knew that this was how I would celebrate,” she says.